18 June 2009, Basle, Switzerland: Lumavita AG, the Swiss biopharmaceutical company specializing in novel anti-infectives for Women’s Health, announces today that it has raised CHF 6m (€4m) in an extension to the Series A round the Company initiated in September 2008. The total raised in this financing round is CHF 24m.
The new funds have been [...]